Pieris Pharmaceuticals, Inc. - Common Stock (PIRS)
13.60
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 1:48 PM EDT

Pieris Pharmaceuticals just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024

Via Benzinga · July 24, 2024

Allarity Therapeutics stock is up on Wednesday as the company pushes ALLR investors to vote in favor of a reverse stock split.
Via InvestorPlace · July 24, 2024

Via Benzinga · July 24, 2024

Pieris Pharmaceuticals stock is up on Wednesday as PIRS investors learn of the company preparing for a merger with Palvella Therapeutics.
Via InvestorPlace · July 24, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Via InvestorPlace · July 24, 2024

Pieris Pharmaceuticals just reported results for the first quarter of 2024.
Via InvestorPlace · May 17, 2024

Via Benzinga · May 16, 2024

Via Benzinga · March 20, 2024

Via Benzinga · March 14, 2024

Via Benzinga · January 31, 2024

Via Benzinga · December 13, 2023

Gainers
Via Benzinga · September 27, 2023

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!
Via InvestorPlace · September 27, 2023

Via Benzinga · August 25, 2023

Via Benzinga · August 25, 2023

Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares gained 57.6% to $1.19 in pre-market trading after the company announced the purchase of shares by company officers.
Via Benzinga · August 25, 2023

It's time to close out this week of trading with an overview of the biggest pre-market stock movers to watch Friday morning!
Via InvestorPlace · August 25, 2023

Gainers Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847.
Via Benzinga · August 24, 2023

Via Benzinga · August 16, 2023

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via Benzinga · July 18, 2023

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher after the company
Via Benzinga · July 18, 2023

Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.
Via InvestorPlace · July 17, 2023